Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-06

ADVB vs FCHS: stock comparison and AI forecast

Advanced Biomed Inc. (ADVB) and First Choice Healthcare Solutions, Inc. (FCHS) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Services-Medical Laboratories

ADVB Advanced Biomed Inc.

Market Cap
$3M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
OTC · Services-Medical Laboratories

FCHS First Choice Healthcare Solutions, Inc.

Market Cap
$150K
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

ADVB · FCHS

Key facts

  • ADVB is 20.9 times larger than FCHS by market capitalization ($3M against $150K).
  • Both companies share the SEC industry classification Services-Medical Laboratories.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricADVBFCHS
Market Cap$3M$150K
P/B Ratio0.34x–
EPS$-0.14$-0.40
Book Value/Share$5.57–

Profitability & Margins

MetricADVBFCHS
ROA–-2562.0%
ROIC–35.4%

Financial Health

MetricADVBFCHS
Current Ratio–0.00x
D/E Ratio0.16x–
Financial Leverage1.16x–
Interest Coverage–-0.1x
Working Capital–-$10M

Cash Flow

MetricADVBFCHS
Operating Cash Flow-$6M-$340K

Income Statement

MetricADVBFCHS
Operating Income–-$3M
Net Income–-$15M
R&D Expense$920K–
SG&A Expense–$3M

Dividend & Shareholder Information

MetricADVBFCHS
Shares Outstanding2M33M
FAQ

ADVB vs FCHS: stock comparison and AI forecast

Which is bigger, ADVB or FCHS?

ADVB is 20.9 times larger than FCHS by market capitalization ($3M against $150K).

Which one does Intratio's AI model rank higher, ADVB or FCHS?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.